Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2003045917A3 Ccr-3 receptor antagonists vii
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003026617A3 (ester)-lysolecithins in liposomes
10/09/2003WO2003016528A3 Oligonucleotide compositions and their use to induce apoptosis
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003006893A3 Methods of inhibiting amyloid toxicity
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002088383A3 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002078747A3 Pregabalin lactose conjugates
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002057484A3 Method and test system for identifying substances which protect nerve cells
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002049599A3 Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound
10/09/2003WO2002043769A3 Neutral and anionic colloidal particles for gene delivery
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002034284A3 Methods of therapy for hiv infection
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002030433A3 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191337 Crystal of bicalutamide and production method thereof
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191315 A chemical intermediate reaction by starting 2,6-diaminopyridine with malic acid and sulfuric acid, salt formation, hydroxylation, chlorination, dehydroxylation, reduction, esterification
10/09/2003US20030191312 Preparing a C2-substituted purine compound, by reacting a C2-halogenated purine with a boronic acid, a hydroxy or amine compounds; dehydrohalogenation, amination, carboxylation; chemical intermediates
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191300 Antisense modulation of bcl-x expression
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191186 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/09/2003US20030191181 4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome P450RAI inhibitory activity
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191176 Stable hydrate of a muscarinic receptor antagonist
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191174 Novel bicyclic compounds
10/09/2003US20030191172 Method of using cyclooxygenase inhibitors and antimuscarinic agents
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191161 Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom
10/09/2003US20030191160 Aids therapy; calibration efficiency of benzimidazole compound
10/09/2003US20030191159 Antisecretory agents; antiulcer agents; adjust absorption
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191153 Antithrombotic amides
10/09/2003US20030191149 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191122 Antidepressants; Alzheimer's disease; Parkinson's disease; central nervous system disorders
10/09/2003US20030191120 Antiparkinsonism drugs
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191111 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191104 Therapy for carbohydrate metabolism disorders
10/09/2003US20030191092 MMP inhibitors
10/09/2003US20030191080 Cardiovascular disorders; hypotensive agents
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191070 Medical composition kit for treating lesioned abnormal tissue
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030191053 Cyclic peptide derivative
10/09/2003US20030191051 Combination therapy for the treatment of bacterial infections
10/09/2003US20030190732 Plasma fraction containing bikunin, method for the production thereof and use of the same
10/09/2003US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190693 Identifying inhibitors and activators of eukaryotic potassium channels
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190607 Polymorphisms in human pyruvate dehydrogenase E1 beta (PDH E1 beta) gene; for analysing allelic variation; bioinformatic applications
10/09/2003US20030190372 Cough depressant composition containing iron for angiotensin-converting enzyme inhibitor inducing cough
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190357 Compositions for delivery of a cortisol antagonist
10/09/2003US20030190310 Primary package containing a low molecular weight peptide-based thrombin inhibitors sealed with a bromobutyl rubber stopper or plunger
10/09/2003US20030190309 Novel probiotics for pet food applications
10/09/2003US20030190299 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative
10/09/2003US20030188740 Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2481253A1 Vegf peptides and their use
10/09/2003CA2480890A1 1-n-aminobenzimidazole derivatives
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480419A1 Antiopoietin-related growth factor
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1564